RAPP CIK: 2012593

Rapport Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY23
FY24
FY25
FY23 – FY25
(positive)
Change from FY23 to FY25
millions USD
FY23:
−27.2
FY24:
−64.8
FY25:
−87.5
Change from FY23 to FY25
millions USD
FY23:
−78.9
FY24:
−170
FY25:
−187
Change from FY23 to FY25
millions USD
FY23:
145
FY24:
222
FY25:
271
millions USD
FY23:
39.1
FY24:
−13.3
FY25:
−4.16
(positive)
Change from FY23 to FY25
millions USD
FY23:
−28.8
FY24:
−67.2
FY25:
−88.1

All amounts in millions USD Data source:SEC EDGAR